Democratic-Led States Defy New Federal Hepatitis B Vaccine Birth Dose Recommendation

Most Democratic-led U.S. states intend to continue universally recommending and administering the hepatitis B vaccine (HBV) at birth, despite new guidance opposing this practice issued last week by a federal vaccine advisory panel handpicked by U.S. Health and Human Services Secretary Robert F. Kennedy Jr.

The Northeast Public Health Collaborative (NEPHC) and the West Coast Health Alliance (WCHA)—formed earlier this year in response to Kennedy’s controversial overhaul of vaccine policy—alongside other Democratic-led states, have resolved to disregard the latest recommendations from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP).

Background: Hepatitis B Risk and Existing Policy

Hepatitis B is a severe, incurable viral infection causing liver damage and hepatocellular carcinoma (HCC). Transmission from mother to child can occur during delivery; without vaccination, approximately 90% of infected infants develop chronic hepatitis B, with 25% dying prematurely from the disease.

Since 1991, ACIP and the American Academy of Pediatrics (AAP) have recommended a universal HBV birth dose within 24 hours of delivery. This policy—credited with a 99% reduction in childhood hepatitis B cases—was the first successful universal strategy after earlier targeted approaches (e.g., screening mothers, vaccinating only infants of infected mothers) failed.

ACIP’s Controversial Overhaul

In June, Kennedy announced a “clean sweep” of ACIP, replacing all 17 incumbent experts with his appointed members, many of whom are vaccine skeptics. During a two-day meeting marked by procedural chaos and misinformation, the new committee voted to restrict HBV birth dose recommendations to:

• Infants of pregnant individuals testing positive for hepatitis B or with unknown status.

• For infants of hepatitis B-negative mothers: “individualized decision-making” (parental consultation with providers) rather than universal vaccination.

• If not administered at birth, delaying the first dose until ≥2 months of age.

Medical Experts Condemn the Decision

Medical experts have strongly criticized this reversal, citing imperfect U.S. maternal screening (50% of infected individuals are asymptomatic and unaware).

Michaela Jackson, Director of Prevention Policy at the Hepatitis B Foundation, noted: “The United States tried targeted strategies (1980s–early 1990s) and they failed. The universal birth dose was the only proven success, driving a 99% decline in cases.”

Democratic-Led States Reaffirm Universal Policy

Despite ACIP’s new stance, Democratic-led states are resisting:

• Northeast Public Health Collaborative (CT, DE, ME, MD, MA, NJ, NY, PA, RI, VT): Recommends universal HBV at birth within 24 hours; infants of infected/unknown-status mothers receive it within 12 hours.

• New York State Department of Health: Affirmed “no deviation from evidence-based policies,” including universal 24-hour HBV doses and full vaccination series completion in infancy.

• Maryland: Issued an advisory to providers and birthing facilities, reiterating the birth dose’s importance, and implemented a standing order to ensure access for all infants up to 18 years.

• Pennsylvania: Insurance Commissioner guaranteed newborn HBV coverage; Governor Josh Shapiro signed an executive order aligning state policies with AAP guidelines.

• West Coast Health Alliance (OR, WA, CA, HI): “Strongly supports universal newborn HBV vaccination.”

• Illinois, Colorado, Michigan, New Mexico, and Minnesota: Confirmed no policy changes, with Illinois codifying CDC schedules and Minnesota’s epidemiologist vowing to advise birth-dose vaccination.

Consequences of State Divergence

State-level policy divergence may lead to inconsistent vaccine uptake. An Oregon Health and Science University (OHSU) analysis—excluding state-level variations—predicts delayed birth doses could cause >1,400 childhood HBV infections in the first year, with 304 subsequent liver cancer cases and 482 related deaths.

John Ward, former CDC Director of Viral Hepatitis and current hepatitis B elimination lead at the Task Force for Global Health, stated: “Targeted vaccination failed in the 1980s–1990s. This ACIP policy risks preventable mother-to-child transmission and unnecessary harm to U.S. infants.”

Sources: NEPHC, WCHA, state health departments, OHSU analysis, medical experts.